Literature DB >> 23014338

Global epidemiology of psoriasis: a systematic review of incidence and prevalence.

Rosa Parisi1, Deborah P M Symmons, Christopher E M Griffiths, Darren M Ashcroft.   

Abstract

The worldwide incidence and prevalence of psoriasis is poorly understood. To better understand this, we performed a systematic review of published population-based studies on the incidence and prevalence of psoriasis. Three electronic databases were searched from their inception dates to July 2011. A total of 385 papers were critically appraised; 53 studies reported on the prevalence and incidence of psoriasis in the general population. The prevalence in children ranged from 0% (Taiwan) to 2.1% (Italy), and in adults it varied from 0.91% (United States) to 8.5% (Norway). In children, the incidence estimate reported (United States) was 40.8/100,000 person-years. In adults, it varied from 78.9/100,000 person-years (United States) to 230/100,000 person-years (Italy). The data indicated that the occurrence of psoriasis varied according to age and geographic region, being more frequent in countries more distant from the equator. Prevalence estimates also varied in relation to demographic characteristics in that studies confined to adults reported higher estimates of psoriasis compared with those involving all age groups. Studies on the prevalence and incidence of psoriasis have contributed to a better understanding of the burden of the disease. However, further research is required to fill existing gaps in understanding the epidemiology of psoriasis and trends in incidence over time.

Entities:  

Mesh:

Year:  2012        PMID: 23014338     DOI: 10.1038/jid.2012.339

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  571 in total

1.  Effects of baicalin cream in two mouse models: 2,4-dinitrofluorobenzene-induced contact hypersensitivity and mouse tail test for psoriasis.

Authors:  Jie Wu; Hong Li; Ming Li
Journal:  Int J Clin Exp Med       Date:  2015-02-15

Review 2.  The Use of Brodalumab in Three Patients with Psoriasis and Psychiatric Comorbidities.

Authors:  Ryan Rivera-Oyola; Roselyn Stanger; Graham H Litchman; Quinn Thibodeaux; John Koo; Richard Fried; Gary Goldenberg; George Han; Sylvia Hsu; Leon Kircik; Melissa Knuckles; Andrea Murina; Jeffrey Weinberg; Jashin J Wu; Mark Lebwohl
Journal:  J Clin Aesthet Dermatol       Date:  2020-12-01

3.  Subjective Health Complaints in Individuals with Psoriasis and Psoriatic Arthritis: Associations with the Severity of the Skin Condition and Illness Perceptions - A Cross-Sectional Study.

Authors:  Emma Charlott Andersson Nordbø; Geir Aamodt; Camilla Martha Ihlebæk
Journal:  Int J Behav Med       Date:  2017-06

4.  Elucidating new drug targets in psoriasis by gene profiling: an opportunity to be seized.

Authors:  Mark R Walter
Journal:  Ann Transl Med       Date:  2015-04

5.  Psoriasis in skin of color: epidemiology, genetics, clinical presentation, and treatment nuances.

Authors:  Andrew F Alexis; Paul Blackcloud
Journal:  J Clin Aesthet Dermatol       Date:  2014-11

Review 6.  Systematic review of cost-effectiveness analyses of treatments for psoriasis.

Authors:  Wei Zhang; Nazrul Islam; Canice Ma; Aslam H Anis
Journal:  Pharmacoeconomics       Date:  2015-04       Impact factor: 4.981

7.  Hodgkin's lymphoma in a patient on adalimumab treatment for psoriasis.

Authors:  Nouf Alballa; Alanoud Alyousef; Albatool Alamari; Ahmed Abdullah Alhumidi; Mohammed Ayesh Zayed; Leena Zeitouni; Fahad Mohammed Alsaif
Journal:  AME Case Rep       Date:  2018-12-24

8.  miR-617 Promotes the Growth of IL-22-Stimulated Keratinocytes Through Regulating FOXO4 Expression.

Authors:  Tao Liu; Xiaomei Feng; Yongmei Liao
Journal:  Biochem Genet       Date:  2020-11-19       Impact factor: 1.890

9.  Safety of Systemic Agents for the Treatment of Pediatric Psoriasis.

Authors:  Inge M G J Bronckers; Marieke M B Seyger; Dennis P West; Irene Lara-Corrales; Megha Tollefson; Wynnis L Tom; Marcia Hogeling; Leah Belazarian; Claus Zachariae; Emmanuel Mahé; Elaine Siegfried; Sandra Philipp; Zsuzsanna Szalai; Ruth Ann Vleugels; Kristen Holland; Ruth Murphy; Eulalia Baselga; Kelly Cordoro; Jo Lambert; Alex Alexopoulos; Ulrich Mrowietz; Wietske Kievit; Amy S Paller
Journal:  JAMA Dermatol       Date:  2017-11-01       Impact factor: 10.282

Review 10.  The role of xenobiotics in triggering psoriasis.

Authors:  Jasna Grželj; Marija Sollner Dolenc
Journal:  Arch Toxicol       Date:  2020-08-24       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.